The observation that ER-α(+) tumours expressed higher levels of hsp-27, as measured by OD when compared with ER-α(−) cancers, might further suggest a prognostic role for overexpressed hsp-27 in breast cancer. This evidence concerns the gene ESR1 and cancer.